In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Lyme Disease Tests are carried out to diagnose infections caused by the tick-borne bacterium Borrelia, which can result in neurological and joint disease. GlobalData uses proprietary data and analytics to provide a comprehensive report on the lyme disease tests devices market, including market shares of different players within Russia. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Russia Lyme Disease Tests Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the lyme disease tests market in Russia was PerkinElmer followed by Meridian Bioscience, Qiagen, Bio-Rad Laboratories, bioMerieux, Thermo Fisher Scientific, ERBA Diagnostics, DiaSorin, Quidelortho and ZEUS Scientific.

This segment includes Lyme Disease Enzyme Immunoassay Tests, Lyme Disease Western Blot Tests, and Lyme Disease Other Tests.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the lyme disease tests devices market within Russia was expected to be over $0.1m in 2022.

For the latest complete market share analysis of lyme disease tests device market in Russia, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.